Results 111 to 120 of about 214,937 (381)
Scientific ReportsHelicobacter pylori (H. pylori), known for causing gastric inflammation, gastritis and gastric cancer, prompted our study to investigate the differential expression of cytokines in gastric tissues, which is crucial for understanding H.
Xing-Tang Yang +6 more
doaj +1 more source
Hubungan Tingkat Pengetahuan Dengan Upaya Pencegahan Kekambuhan Gastritis Di Wilayah Kerja Puskesmas Gatak Sukoharjo [PDF]
, 2016 Gastritis is a digestive disorder that is most commonly encountered in clinical practice. In 2014, gastritisincluded inthe fivediseases inSukoharjo. In work area health Gatak Sukoharjo, increased cases ofgastritisfromyear to year.To avoid the occurrence ...
, Fahrun Nur, S.Kep.,Ns., M.Kes. +2 more
core
Alimentary Pharmacology &Therapeutics, EarlyView.BQT remains the most effective, safe, and practical regimen for H. pylori eradication, ensuring high cure rates across diverse resistance patterns and clinical settings. ABSTRACT Background Classic bismuth quadruple therapy (BQT)—the combination of a proton pump inhibitor, bismuth, tetracycline, and metronidazole—is a standard regimen for treating ...
Javier P. Gisbert +2 more
wiley +1 more source
\u3cem\u3eHelicobacter pylori\u3c/em\u3e infection in Havana, Cuba. Prevalence and \u3cem\u3ecagA\u3c/em\u3e status of the strains [PDF]
, 2005 There is a great paucity of information about Helicobacter pylori infection in the countries of the Caribbean basin. Almost no studies have been performed to determine the prevalence, antibiotic resistance or virulence factors of the bacterium.
Camou-Juncas, Christine +12 more
core +1 more source
Hashimoto’s Thyroiditis and Autoimmune Gastritis
Frontiers in Endocrinology, 2017 The term “thyrogastric syndrome” defines the association between autoimmune thyroid disease and chronic autoimmune gastritis (CAG), and it was first described in the early 1960s.
M. Cellini +6 more
semanticscholar +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
INDICATORS OF CELLULAR IMMUNITY IN THE BLOOD OF PATIENTS WITH CHRONIC AND CHRONIC ATROPHIC GASTRITIS
Siberian Journal of Life Sciences and Agriculture, 2019 Helicobacter pylori is one of the common causes of chronic gastritis. In our study, we studied the indicators of cellular immunity in patients with chronic gastritis and chronic atrophic gastritis in the background of Helicobacter pylori infection ...
Olga Valentinovna Smirnova +1 more
doaj +1 more source
Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
British Journal of Pharmacology, EarlyView.Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman +3 more
wiley +1 more source
Frontiers in Immunology, 2018 Background Suppression of gastric acid by proton pump inhibitors is associated with the increase of Lactobacillus in human gut microbiota. Gastric acid secretion is also suppressed by Helicobacter pylori infection and following atrophic gastritis ...
Chikara Iino +6 more
semanticscholar +1 more source
Evaluation of screening tests for autoimmune gastritis in histopathologically confirmed Japanese patients, and re-evaluation of histopathological classification [PDF]
, 2022 Yasuhiro Wada +10 more
openalex +1 more source